EIF2A and early-onset autosomal dominant Alzheimer disease: For instance, in an Alzheimer’s disease (AD) mouse model, GCN2 deletion reduced phosphorylated eIF2a (p-eIF2a) levels and improved spatial memory [46] while in a different model, GCN2 deletion seems to be deleterious [47].